CASE REPORT
The nurse as a member of an interprofessional team in the care
of the oral cavity of cancer patients
1
Department of Nursing, Faculty of Health, Catholic University, Ruzomberok, Slovak Republic
2
Department of Radiation and Clinical Oncology, Central Military Hospital – University Hospital, Ruzomberok, Slovak Republic
Submission date: 2019-07-11
Final revision date: 2020-05-19
Acceptance date: 2020-08-21
Publication date: 2020-09-30
Medical Studies 2020;36(3):230-234
TOPICS
ABSTRACT
Anti-tumour treatment includes surgical, radiation, medication (chemotherapy, hormonal and biological treatment), supportive, and in some cases also palliative treatment. Chemotherapy and radiotherapy, or a combination of the two, involve the most clinical manifestations of adverse effects 1, 2. Adverse effects may be local or systematic and often they subside in the course of several weeks and months after the end of treatment [3, 4]. In the case of patients with unfavourable prognosis, the adverse effects continue for the rest of their life. One of the most frequently occurring complications is damage of oral mucosa [5, 6]. The oral cavity is not only endangered by radiotherapy (particularly with radiation in the area of head and neck) and chemotherapy, but it also suffers the consequences of neutropaenia and overall weakening of the body. The role of professionals is to use timely supportive and targeted treatment to reduce the damage and to attenuate the accompanying symptoms such as pain, dry mouth, xerostomia, oral infection, lack of appetite, swallowing disorders, and others.
REFERENCES (20)
1.
Hudáková Z, Fialová A, Kokoruďová J. Onkologické ošetrovateľstvo. Verbum, Ružomberok 2012.
2.
Vorlíček J, Abrahámová J, Vorlíčková H. Klinická onkologie pro sestry. Grada, Praha, 2012.
3.
Vokurka S. Mukozitída dutiny ústní po chemoterapii a aktinoterapii v bežné praxi. Interní Medicína 2009; 2: 77-79.
4.
Hudáková, Z, Novysedláková, M. Onkologické ošetrova-teľstvo 2. Verbum, Ružomberok 2012.
5.
O´Connor P, Bissn J, Asplin P, Gahir D. Retrospective analysis of self-reporting pain scores and pain management during head and neck IMRT radiotherapy: a single institution experience. Radiography 2017; 23: 103-106.
6.
Rosenberg V. Orálna mukozitída pri rádioterapii nádorov hlavy a krku a možnosti jej terapeutického ovplyvnenia. Onkológia 2014; 9: 308-310.
7.
Franco PL, Martini S, Di Muzio J, Cavallin C, Arcadipane F, Rampino M, Ostellino O, Pecorari G, Garzino Demo P, Fasolis M, Airoldi M, Ricardi U. Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer. Med Onkol 2017; 34: 9-13.
8.
Hajdu SF. Swallowing therapy and progressive resistance training in head and neck cancer patients undergoing radiotherapy treatment: randomized control trial protocol and preliminary data. Acta Oncol 2017; 56: 354-359.
9.
Lalla R, Sonis S, Peterson D. Management of oral mucositis in patients with cancer. Dent Clin North Am 2008; 52: 61-viii.
10.
Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy a randomized controlled trial. Support Care Cancer 2013; 21: 1421-1428.
11.
Araujo NM, Luz MH, da Silva GR, Andrade EM, Nunes LC, Moura RO. Cancer patients with oral mucositis: challenges for nursing care. Revista Latino-Americana de Enfermagem 2015; 23: 267-274.
12.
Murphy BA. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. J Pain Symptom Manag 2009; 38: 522- 532.
13.
Bučková S, Karabová Z. Úroveň vedomostí sestier o febrilnej neutropénii v onkologickom ošetrovateľstve. Diagnóza v ošetřovatelství 2013; 9: 5-7.
14.
British Society for Disability and Oral Health. The Oral Management of Oncology Patients Requiring Radiotherapy, Chemotherapy and/or Bone Marrow Transplantation. 2018; 85.
15.
Knoos M, Ostman M. Oral Assessment Guide – test of reliability and validity for patients receiving radiotherapy to the head and neck region. Eur J Cancer Care 2010; 19: 53-60.
16.
Bužgová R, Sikorová L, Kozáková R, Jarošová D. Hodnotící nástroje pro zjisťování potřeb pacientu v paliativní péči. Onkologie 2013; 7: 310-314.
17.
Jurga M. Klinická a radiačná onkológia založená na dôkazoch. Osveta, Martin 2010.
18.
National Institute of Dental and Craniofacial Research. Prevention and management of oral complications head and neck radiation therapy. 2009. 10 p. www.nidcr.nih.gov.
19.
Wonk MH. Oral Complications and Management Strategies for Patients Undergoing Cancer Therapy. Sci World J 2014; 2014: 581795.
20.
Elad S. The MASCC/ISOO Mucositis Guedelines 2019 Update: introduction to the first set of article. Supportive Care in Cancer 2019, 27: 3929-3931.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
